Published in J Drugs Dermatol on April 01, 2012
CXCL10 is critical for the progression and maintenance of depigmentation in a mouse model of vitiligo. Sci Transl Med (2014) 1.50
Tumour necrosis factor-α inhibition can stabilize disease in progressive vitiligo. Br J Dermatol (2015) 1.42
Simvastatin prevents and reverses depigmentation in a mouse model of vitiligo. J Invest Dermatol (2014) 1.03
Increased Tumor Necrosis Factor (TNF)-α and its promoter polymorphisms correlate with disease progression and higher susceptibility towards vitiligo. PLoS One (2012) 0.87
Interfering with the IFN-γ/CXCL10 pathway to develop new targeted treatments for vitiligo. Ann Transl Med (2015) 0.81
Vitiligo and alopecia areata: apples and oranges? Exp Dermatol (2013) 0.79
Immunophenotypic characterization of lymphoid cell infiltrates in vitiligo. Clin Exp Immunol (2013) 0.78
MHC class II super-enhancer increases surface expression of HLA-DR and HLA-DQ and affects cytokine production in autoimmune vitiligo. Proc Natl Acad Sci U S A (2016) 0.78
Evaluation of the Efficacy of Topical Tetracycline in Enhancing the Effect of Narrow Band UVB against Vitiligo: A Double-Blind, Randomized, Placebo-Controlled Clinical Trial. ISRN Dermatol (2014) 0.75
Multiple Autoimmune Skin Manifestations in a Patient with Crohn's Disease Treated with a Tumor Necrosis Factor-Alpha Blocker. Ann Dermatol (2015) 0.75
Propranolol for severe infantile hemangiomas: follow-up report. Pediatrics (2009) 2.76
Antioxidant supplementation increases the risk of skin cancers in women but not in men. J Nutr (2007) 2.66
Variant of TYR and autoimmunity susceptibility loci in generalized vitiligo. N Engl J Med (2010) 2.47
Seroprevalence and risk factors of chikungunya virus infection in Mayotte, Indian Ocean, 2005-2006: a population-based survey. PLoS One (2008) 2.14
Post-epidemic Chikungunya disease on Reunion Island: course of rheumatic manifestations and associated factors over a 15-month period. PLoS Negl Trop Dis (2009) 1.87
Genome-wide association analyses identify 13 new susceptibility loci for generalized vitiligo. Nat Genet (2012) 1.81
A prevalent mutation with founder effect in xeroderma pigmentosum group C from north Africa. J Invest Dermatol (2010) 1.61
Interventions for vitiligo. Cochrane Database Syst Rev (2015) 1.57
Segmental vitiligo associated with generalized vitiligo (mixed vitiligo): a retrospective case series of 19 patients. J Am Acad Dermatol (2011) 1.48
Two patients with imported acute neuroschistosomiasis due to Schistosoma mansoni. J Travel Med (2010) 1.43
SCN9A mutations define primary erythermalgia as a neuropathic disorder of voltage gated sodium channels. J Invest Dermatol (2005) 1.41
Common variants in FOXP1 are associated with generalized vitiligo. Nat Genet (2010) 1.25
Factors associated with persistence of arthralgia among Chikungunya virus-infected travellers: report of 42 French cases. J Clin Virol (2009) 1.22
Destructive arthritis in a patient with chikungunya virus infection with persistent specific IgM antibodies. BMC Infect Dis (2009) 1.18
Comprehensive association analysis of candidate genes for generalized vitiligo supports XBP1, FOXP3, and TSLP. J Invest Dermatol (2010) 1.14
Quinine-resistant malaria in traveler returning from Senegal, 2007. Emerg Infect Dis (2010) 1.11
Field evaluation of clinical features during chikungunya outbreak in Mayotte, 2005-2006. Trop Med Int Health (2010) 1.08
Genome-wide analysis identifies a quantitative trait locus in the MHC class II region associated with generalized vitiligo age of onset. J Invest Dermatol (2011) 1.08
Reimbursement of malaria chemoprophylaxis for travellers from Europe to Sub-Saharan Africa: Cost-effectiveness analysis from the perspective of the French national health insurance system. Health Policy (2008) 1.03
Severe bullous skin lesions associated with Chikungunya virus infection in small infants. Eur J Pediatr (2009) 1.03
Human RHOH deficiency causes T cell defects and susceptibility to EV-HPV infections. J Clin Invest (2012) 1.00
Segmental vitiligo as the possible expression of cutaneous somatic mosaicism: implications for common non-segmental vitiligo. Pigment Cell Melanoma Res (2008) 0.96
In vivo and in vitro evidence of dermal fibroblasts influence on human epidermal pigmentation. Pigment Cell Res (2006) 0.95
Molecular diagnosis of oculocutaneous albinism: new mutations in the OCA1-4 genes and practical aspects. Pigment Cell Melanoma Res (2008) 0.95
Buruli ulcer in long-term traveler to Senegal. Emerg Infect Dis (2009) 0.95
Evaluation of the prognostic significance of serum galectin-3 in American Joint Committee on Cancer stage III and stage IV melanoma patients. Melanoma Res (2009) 0.93
Cutaneous manifestations in Costello and cardiofaciocutaneous syndrome: report of 18 cases and literature review. Pediatr Dermatol (2013) 0.93
Imported cutaneous melioidosis in traveler, Belgium. Emerg Infect Dis (2007) 0.92
A novel mutation in the fatty acid transport protein 4 gene in a patient initially described as affected by self-healing congenital verruciform hyperkeratosis. Am J Med Genet A (2010) 0.91
Interpretation of plasma PTH concentrations according to 25OHD status, gender, age, weight status, and calcium intake: importance of the reference values. J Clin Endocrinol Metab (2014) 0.91
Worsening of vitiligo and onset of new psoriasiform dermatitis following treatment with infliximab. J Cutan Med Surg (2011) 0.90
Cluster of eosinophilic meningitis attributable to Angiostrongylus cantonensis infection in French policemen troop returning from the Pacific Islands. Travel Med Infect Dis (2008) 0.90
Developing core outcome set for vitiligo clinical trials: international e-Delphi consensus. Pigment Cell Melanoma Res (2015) 0.89
Clinical phenotype of scabies by age. Pediatrics (2014) 0.89
Functional MC1R-gene variants are associated with increased risk for severe photoaging of facial skin. J Invest Dermatol (2009) 0.89
Prevalence of inherited ichthyosis in France: a study using capture-recapture method. Orphanet J Rare Dis (2014) 0.89
An imported case of Chikungunya fever from Madagascar: use of the sentinel traveller for detecting emerging arboviral infections in tropical and European countries. Travel Med Infect Dis (2008) 0.88
Seroepidemiology of Dengue virus in Mayotte, Indian Ocean, 2006. PLoS One (2010) 0.88
Functional skin adaptation in infancy - almost complete but not fully competent. Exp Dermatol (2010) 0.88
Beyond vitiligo guidelines: combined stratified/personalized approaches for the vitiligo patient. Exp Dermatol (2014) 0.87
[Bullous pemphigoid, primary biliary cirrhosis and vitiligo: a multiple autoimmune syndrome?]. Ann Med Interne (Paris) (2002) 0.87
Type I interferon signature in the initiation of the immune response in vitiligo. Pigment Cell Melanoma Res (2014) 0.86
The lymphoid variant of hypereosinophilic syndrome: study of 21 patients with CD3-CD4+ aberrant T-cell phenotype. Medicine (Baltimore) (2014) 0.85
Molecular blocking of CD23 supports its role in the pathogenesis of arthritis. PLoS One (2009) 0.85
Percutaneous cryoablation of symptomatic localized venous malformations: preliminary short-term results. J Vasc Interv Radiol (2013) 0.84
Follicular vitiligo: a new form of vitiligo. Pigment Cell Melanoma Res (2012) 0.84
Age-related differences in sensitivity of peripheral blood monocytes to lipopolysaccharide and Staphylococcus aureus toxin B in atopic dermatitis. J Invest Dermatol (2007) 0.84
Ectopic cutaneous schistosomiasis-perigenital infiltrative granulomata in a 34-year-old French pregnant woman. Travel Med Infect Dis (2008) 0.84
Epidemiology of genital herpes simplex virus infections in a community-based sample in France: results of the HERPIMAX study. Sex Transm Dis (2005) 0.83
IFAG and childhood rosacea: a possible link? Pediatr Dermatol (2013) 0.83
Koebner's phenomenon in vitiligo: European position paper. Pigment Cell Melanoma Res (2011) 0.83
Hematoma-like metastases. J Am Acad Dermatol (2006) 0.83
Extensive cutaneous larva migrans with folliculitis mimicking multimetameric herpes zoster presentation in an adult traveler returning from Thailand. J Travel Med (2006) 0.83
Sun-reactive Skin Type in 4912 French adults participating in the SU.VI.MAX study. Photochem Photobiol (2005) 0.82
Quality assessment of ordinal scale reproducibility: log-linear models provided useful information on scale structure. J Clin Epidemiol (2008) 0.81
Immunogenicity and tolerability of yellow fever vaccination in 23 French HIV-infected patients. Curr HIV Res (2010) 0.81
Interest of high-dose pulse corticosteroid therapy combined with methotrexate for severe alopecia areata: a retrospective case series. Dermatology (2012) 0.81
Factors associated with impaired quality of life in adult patients suffering from ichthyosis. Acta Derm Venereol (2014) 0.81
Alternative procedure to allow continuation of dapsone therapy despite serious adverse reaction in a case of dapsone-sensitive erythema elevatum diutinum. Dermatology (2012) 0.81
Cutaneous hyphomycosis due to Paecilomyces lilacinus. Acta Derm Venereol (2012) 0.80
Study of CCN3 (NOV) and DDR1 in normal melanocytes and vitiligo skin. Exp Dermatol (2012) 0.80
High resolution mapping of OCA2 intragenic rearrangements and identification of a founder effect associated with a deletion in Polish albino patients. Hum Genet (2010) 0.80
In vitro research on vitiligo: strategies, principles, methodological options and common pitfalls. Exp Dermatol (2012) 0.80
Painful Buruli ulcer in a Malian visitor to France. Acta Derm Venereol (2010) 0.80
Cole Disease Results from Mutations in ENPP1. Am J Hum Genet (2013) 0.80
A genome-wide association study in Caucasian women points out a putative role of the STXBP5L gene in facial photoaging. J Invest Dermatol (2012) 0.80
Neoadjuvant polychemotherapy in locally advanced Merkel cell carcinoma. Nat Rev Clin Oncol (2009) 0.79
Detection of an intragenic deletion expands the spectrum of CTSC mutations in Papillon-Lefèvre syndrome. J Invest Dermatol (2007) 0.79
Cluster of chikungunya virus infection in travelers returning from Senegal, 2006. J Travel Med (2009) 0.79
Latent class analysis of a series of 717 patients with vitiligo allows the identification of two clinical subtypes. Pigment Cell Melanoma Res (2013) 0.79
Association between dietary intake of n-3 polyunsaturated fatty acids and severity of skin photoaging in a middle-aged Caucasian population. J Dermatol Sci (2013) 0.79
Assessment of tyrosinase variants and skin cancer risk in a large cohort of French subjects. J Dermatol Sci (2011) 0.78
Halo nevi association in nonsegmental vitiligo affects age at onset and depigmentation pattern. Arch Dermatol (2012) 0.78
MC1R gene polymorphism affects skin color and phenotypic features related to sun sensitivity in a population of French adult women. Photochem Photobiol (2009) 0.78
Methotrexate for the treatment of generalized vitiligo. Saudi Pharm J (2013) 0.78
Development and validation of the K-VSCOR for scoring Koebner's phenomenon in vitiligo/non-segmental vitiligo. Pigment Cell Melanoma Res (2013) 0.78
Recurrent superficial mucoceles associated with lichenoid disorders. J Oral Maxillofac Surg (2006) 0.78
A case of primary erythermalgia with encephalopathy. J Neurol (2009) 0.77
Burden of inherited ichthyosis: a French national survey. Acta Derm Venereol (2015) 0.77
Mast cells as possible targets of propranolol therapy: an immunohistological study of beta-adrenergic receptors in infantile haemangiomas. Histopathology (2014) 0.77
Quick and Easy Screening for Vitamin D Insufficiency in Adults: A Scoring System to Be Implemented in Daily Clinical Practice. Medicine (Baltimore) (2016) 0.76
Prevalence and risk factors of vitamin D deficiency in inherited ichthyosis: a French prospective observational study performed in a reference center. Orphanet J Rare Dis (2014) 0.76
Relationships between visual and tactile features and biophysical parameters in human facial skin. Skin Res Technol (2007) 0.76
Antioxidant supplementation and risk of skin cancers. Arch Dermatol (2010) 0.75
Long-term Use of Systemic Treatments for Moderate-to-Severe Atopic Dermatitis in Adults: A Monocentric Retrospective Study. Acta Derm Venereol (2016) 0.75
Intensive care unit admission for pandemic (H1N1) 2009, Reunion Island, 2009. Emerg Infect Dis (2011) 0.75
Dietary monounsaturated fatty acids intake and risk of skin photoaging. PLoS One (2012) 0.75
Treatment of pre-ulcerative necrobiosis lipoidica with infliximab. Acta Derm Venereol (2011) 0.75
Correction: Experimental Treatment with Favipiravir for Ebola Virus Disease (the JIKI Trial): A Historically Controlled, Single-Arm Proof-of-Concept Trial in Guinea. PLoS Med (2016) 0.75
Antioxidant supplements and their risk of skin cancers. Clin Dermatol (2010) 0.75